Ajanta Pharma Ltd News
Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4_61701
In Q4FY22, Ajanta's earnings before interest, taxes, depreciation, and amortization declined 20 per cent year-on- year to Rs 207 crore.
 "Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4_61701")
Updated On : 11 May 2022 | 12:27 PM IST
Ajanta Pharma gains 5% on share buyback plan, board to meet on Dec 28_10974
The board of directors of the company is scheduled to consider a proposal for buy-back of equity shares on Tuesday, December 28.
Updated On : 24 Dec 2021 | 11:27 AM IST
